Canton Strategic Holdings (CNTN) Other Gross PP&E Adjustments (2020 - 2025)
Canton Strategic Holdings posted quarterly Other Gross PP&E Adjustments of -$403744.0 for Q4 2025, up 55.34% year-on-year from -$259913.1 in Q4 2024, and up 55.34% on a QoQ basis from -$904000.0 in Q4 2024.
Canton Strategic Holdings (CNTN) has 6 years of Other Gross PP&E Adjustments data on file, last reported at -$403744.0 in Q4 2025.
- For the quarter ending Q4 2025, Other Gross PP&E Adjustments rose 55.34% year-over-year to -$403744.0; the trailing twelve-month figure through Mar 2026 stood at -$403744.0 (up 55.34% YoY), and the FY2025 full-year result was -$403744.0, up 55.34% from the prior year.
- Other Gross PP&E Adjustments for Q4 2025 stood at -$403744.0, up from -$904000.0 in the prior quarter.
- Across five years, Other Gross PP&E Adjustments topped out at -$336000.0 in Q4 2021 and bottomed at -$904000.0 in Q4 2024.
- The 5-year median for Other Gross PP&E Adjustments is -$534000.0 (2022), against an average of -$582148.8.
- The widest annual swing landed in 2021, when Other Gross PP&E Adjustments tumbled 1876.47%; it then surged 55.34% in 2025.
- A 5-year view of Other Gross PP&E Adjustments shows it stood at -$336000.0 in 2021, then sank by 58.93% to -$534000.0 in 2022, then plunged by 37.27% to -$733000.0 in 2023, then fell by 23.33% to -$904000.0 in 2024, then soared by 55.34% to -$403744.0 in 2025.
- The last three Other Gross PP&E Adjustments figures came in at -$403744.0 (Q4 2025), -$904000.0 (Q4 2024), and -$733000.0 (Q4 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Gross PP&E Adjustments (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -83,048.00 |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | -60,691.22 |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -285.20 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -892,000.00 |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | -1.69 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | -189.30 Mn |
| 10 | Canton Strategic Holdings | 643.89 Mn | 602.36 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -403,744.00 |
| Dec 31, 2025 | -403,744.00 |
| Dec 31, 2024 | -904,000.00 |
| Dec 31, 2024 | -904,000.00 |
| Dec 31, 2023 | -733,000.00 |
| Dec 31, 2023 | -733,000.00 |
| Dec 31, 2022 | -534,000.00 |
| Dec 31, 2022 | -534,000.00 |
| Dec 31, 2021 | -336,000.00 |
| Dec 31, 2021 | -336,000.00 |
| Dec 31, 2020 | -17,000.00 |
| Dec 31, 2020 | -17,000.00 |